ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

15,194Medicare Part D Prescriptions Filled, Including Refills

Rank: 17 out of 617

$932K Total Retail Price of All Prescriptions

Rank: 6 out of 617

444 Patients Receiving at Least One Drug in Part D
72%Patients 65 Years and Older
58% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Nebraska
Lower avg

Schedule Two
Controlled Substances

10% of this provider’s 444 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

19% of this provider’s 444 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

1% of this provider’s 11,417 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$61 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

34 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Nebraska
LEVOTHYROXINE SODIUM 602 506 1 1
WARFARIN SODIUM 527 399 2 7
FUROSEMIDE 509 391 3 4
OMEPRAZOLE 501 387 4 3
HYDROCODONE-ACETAMINOPHEN 457 261 S3 5 8
POTASSIUM CHLORIDE 452 376 6 10
METOPROLOL TARTRATE 355 311 7 11
SIMVASTATIN 309 248 8 2
METFORMIN HCL 252 194 9 9
LISINOPRIL 252 163 9 5
AMLODIPINE BESYLATE 226 202 11 6
ATORVASTATIN CALCIUM 206 195 12 14
METOPROLOL SUCCINATE 199 197 13 12
GABAPENTIN 183 153 14 16
CITALOPRAM HBR 180 139 15 18
SERTRALINE HCL 156 142 16 20
ALLOPURINOL 147 131 17 27
RANITIDINE HCL 146 119 18 40
QUETIAPINE FUMARATE 146 129 18 78
ZOLPIDEM TARTRATE 139 87 20 23
GLIMEPIRIDE 136 110 21 33
ATENOLOL 134 94 22 17
PREDNISONE 132 100 23 31
NAMENDA 132 120 23 35
MELOXICAM 131 108 25 24
FAMOTIDINE 129 106 26 54
TRAMADOL HCL 126 89 27 15
PANTOPRAZOLE SODIUM 123 115 28 37
DONEPEZIL HCL 121 109 29 30
POLYETHYLENE GLYCOL 3350 112 88 30 32
CLOPIDOGREL 109 100 31 53
SPIRONOLACTONE 107 70 32 42
ABILIFY 106 66 33 131
VESICARE 105 102 34 95
NEXIUM 103 46 35 43
LANTUS 102 70 36 39
TAMSULOSIN HCL 101 94 37 26
LYRICA 101 23 37 92
ZETIA 96 84 39 77
ISOSORBIDE MONONITRATE ER 94 69 40 52
CELEBREX 90 85 41 63
VENLAFAXINE HCL ER 90 68 41 76
ADVAIR DISKUS 89 78 43 38
CYCLOBENZAPRINE HCL 89 47 R 43 74
TRIAMTERENE-HCTZ 87 81 45 47
PLAVIX 85 72 46 86
LOSARTAN POTASSIUM 84 80 47 22
SUCRALFATE 83 46 48 143
SULFAMETHOXAZOLE-TRIMETHOPRIM 80 62 49 91
CIPROFLOXACIN HCL 78 59 50 60
CRESTOR 75 62 51 28
ALENDRONATE SODIUM 72 57 52 25
DIVALPROEX SODIUM 71 63 53 111
HYDROCHLOROTHIAZIDE 71 55 53 13
LEVETIRACETAM 71 19 53 166
CEFDINIR 69 52 56 169
PRAMIPEXOLE DIHYDROCHLORIDE 69 61 56 153
DIOVAN 67 67 58 41
TRAZODONE HCL 67 58 58 51
TERAZOSIN HCL 67 66 58 96
TRICOR 65 55 61 83
FENTANYL 64 51 S2 62 45
ROPINIROLE HCL 64 33 62 66
SINGULAIR 64 44 62 106
PHENYTOIN SODIUM EXTENDED 58 23 65 121
FLUTICASONE PROPIONATE 57 44 66 36
DOXYCYCLINE HYCLATE 57 38 66 113
NITROFURANTOIN 56 37 68 251
SPIRIVA 55 39 69 61
MIRTAZAPINE 55 54 69 50
RAMIPRIL 55 48 69 67
CLONIDINE HCL 54 20 72 55
ENALAPRIL MALEATE 54 54 72 34
PRAVASTATIN SODIUM 54 54 72 21
ACTOS 53 42 75 85
CEPHALEXIN 53 28 75 68
CARBIDOPA-LEVODOPA 52 52 77 69
RISPERIDONE 51 51 78 71
OXYCODONE-ACETAMINOPHEN 51 28 S2 78 93
NYSTATIN 51 32 78 228
BENAZEPRIL HCL 51 51 78 44
CYMBALTA 50 25 82 49
DIGOXIN 50 48 82 48
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.